Neural grafts containing exosomes derived from Schwann cell-like cells promote peripheral nerve regeneration in rats

Abstract

Background: Schwann cell-like cells (SCLCs), differentiated from mesenchymal stem cells, have shown promising outcomes in the treatment of peripheral nerve injuries in preclinical studies. However, certain clinical obstacles limit their application. Hence, the primary aim of this study was to investigate the role of exosomes derived from SCLCs (SCLCs-exo) in peripheral nerve regeneration. Methods: SCLCs were differentiated from human amniotic mesenchymal stem cells (hAMSCs) in vitro and validated by immunofluorescence, real-time quantitative PCR and western blot analysis. Exosomes derived from hAMSCs (hAMSCs-exo) and SCLCs were isolated by ultracentrifugation and validated by nanoparticle tracking analysis, WB analysis and electron microscopy. A prefabricated nerve graft was used to deliver hAMSCs-exo or SCLCs-exo in an injured sciatic nerve rat model. The effects of hAMSCs-exo or SCLCs-exo on rat peripheral nerve injury (PNI) regeneration were determined based on the recovery of neurological function and histomorphometric variation. The effects of hAMSCs-exo or SCLCs-exo on Schwann cells were also determined via cell proliferation and migration assessment. Results: SCLCs significantly expressed the Schwann cell markers glial fibrillary acidic protein and S100. Compared to hAMSCs-exo, SCLCs-exo significantly enhanced motor function recovery, attenuated gastrocnemius muscle atrophy and facilitated axonal regrowth, myelin formation and angiogenesis in the rat model. Furthermore, hAMSCs-exo and SCLCs-exo were efficiently absorbed by Schwann cells. However, compared to hAMSCs-exo, SCLCs-exo significantly promoted the proliferation and migration of Schwann cells. SCLCs-exo also significantly upregulated the expression of a glial cell-derived neurotrophic factor, myelin positive regulators (SRY-box transcription factor 10, early growth response protein 2 and organic cation/carnitine transporter 6) and myelin proteins (myelin basic protein and myelin protein zero) in Schwann cells. Conclusions: These findings suggest that SCLCs-exo can more efficiently promote PNI regeneration than hAMSCs-exo and are a potentially novel therapeutic approach for treating PNI.

Keywords

Schwann cell-like cells / Exosomes / Peripheral nerve injury / Mesenchymal stem cells / Nerve regeneration

References

[1] Gu X, Ding F, Yang Y, Liu J. Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration. Prog Neurobiol. 2011; 93: 204-30.

[2] Lee JH, Roy J, Sohn HM, Cheong M, Liu J, Stammers AT, et al. Magnesium in a polyethylene glycol formulation provides neuroprotection after unilateral cervical spinal cord injury. Spine. 2010; 35: 2041-8.

[3] Geissler J, Stevanovic M. Management of large peripheral nerve defects with autografting. Injury. 2019; 50: S64-s67.

[4] Behtaj S, Ekberg JAK, St John JA. Advances in electrospun nerve guidance conduits for engineering neural regeneration. Pharmaceutics. 2022; 14: 219.

[5] Yang CY, Huang WY, Chen LH, Liang NW, Wang HC, Lu J, et al. Neural tissue engineering: the influence of scaffold surface topography and extracellular matrix microenvironment. J Mater Chem B. 2021; 9: 567-84.

[6] Sarker MD, Naghieh S, McInnes AD, Schreyer DJ, Chen X. Regeneration of peripheral nerves by nerve guidance conduits: influence of design, biopolymers, cells, growth factors, and physical stimuli. Prog Neurobiol. 2018; 171: 125-50.

[7] Boerboom A, Dion V, Chariot A, Franzen R. Molecular mechanisms involved in Schwann cell plasticity. Front Mol Neurosci. 2017; 10: 38.

[8] Arthur-Farraj P, Coleman MP. Lessons from injury: how nerve injury studies reveal basic biological mechanisms and therapeutic opportunities for peripheral nerve diseases. Neurotherapeutics. 2021; 18: 2200-21.

[9] Chen W, Wei ZR, Wu BH, Yang CL, Jin WH, Gong FY, et al. Effects of combined transplantation of rat Schwann cells and fibroblasts on nerve regeneration of denervated perforator flaps in rats and the mechanism. Chinese journal of burns. 2019; 35: 134-42.

[10] Zigmond RE, Echevarria FD. Macrophage biology in the peripheral nervous system after injury. Prog Neurobiol. 2019; 173: 102-21.

[11] Song L, Guo Q, Guo J, Xu X, Xu K, Li Y et al. Brachial plexus bridging with specific extracellular matrix modified chitosan/silk scaffold: a new expand of tissue engineered nerve graft. J Neural Eng 2022, 19, 026010.

[12] Zheng T, Wu L, Sun S, Xu J, Han Q, Liu Y, et al. Co-culture of Schwann cells and endothelial cells for synergistically regulating dorsal root ganglion behavior on chitosan-based anisotropic topology for peripheral nerve regeneration. Burns Trauma. 2022; 10: tkac030.

[13] Chen W, Ji L, Wei Z, Yang C, Chang S, Zhang Y, et al. miR-146a-3p suppressed the differentiation of hAMSCs into Schwann cells via inhibiting the expression of ERBB2. Cell Tissue Res. 2021; 384: 99-112.

[14] Jones S, Eisenberg HM, Jia X. Advances and future applications of augmented peripheral nerve regeneration. Int J Mol Sci. 2016; 17: 1494.

[15] Lotfi L, Khakbiz M, Moosazadeh Moghaddam M, Bonakdar S. A biomaterials approach to Schwann cell development in neural tissue engineering. J Biomed Mater Res A. 2019; 107: 2425-46.

[16] Hopf A, Schaefer DJ, Kalbermatten DF, Guzman R, Madduri S. Schwann cell-like cells: origin and usability for repair and regeneration of the peripheral and central nervous system. Cell. 2020; 9: 1990.

[17] Borlongan CV. Remyelinating the transected peripheral nerve by fabricated Schwann cells derived from bone marrow. Exp Neurol. 2010; 225: 243-5.

[18] Ao Q, Fung CK, Tsui AY, Cai S, Zuo HC, Chan YS, et al. The regeneration of transected sciatic nerves of adult rats using chitosan nerve conduits seeded with bone marrow stromal cell-derived Schwann cells. Biomaterials. 2011; 32: 787-96.

[19] Jiang L, Mee T, Zhou X, Jia X. Augmenting peripheral nerve regeneration with adipose-derived stem cells. Stem Cell Rev Rep. 2021; 18: 544-58.

[20] Ching RC, Wiberg M, Kingham PJ. Schwann cell-like differentiated adipose stem cells promote neurite outgrowth via secreted exosomes and RNA transfer. Stem Cell Res Ther. 2018; 9: 266.

[21] Chen W, Xiao S, Wei Z, Deng C, Nie K, Wang D. Schwann cell-like cells derived from human amniotic mesenchymal stem cells promote peripheral nerve regeneration through a MicroRNA-214/c-Jun pathway. Stem Cells Int. 2019; 2019: 2490761.

[22] Jiang TM, Yang ZJ, Kong CZ, Zhang HT. Schwann-like cells can be induction from human nestin-positive amniotic fluid mesenchymal stem cells. In vitro cellular & developmental biology Animal. 2010; 46: 793-800.

[23] Jung N, Park S, Choi Y, Park JW, Hong YB, Park HH, et al. Tonsil-derived mesenchymal stem cells differentiate into a Schwann cell phenotype and promote peripheral nerve regeneration. Int J Mol Sci. 2016; 17: 1867.

[24] Martens W, Sanen K, Georgiou M, Struys T, Bronckaers A, Ameloot M, et al. Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue-engineered collagen construct in vitro. FASEB J. 2014; 28: 1634-43.

[25] Huang Z, Powell R, Phillips JB, Haastert-Talini K. Perspective on Schwann cells derived from induced pluripotent stem cells in peripheral nerve tissue engineering. Cell. 2020; 9: 2497.

[26] Liu CY, Yin G, Sun YD, Lin YF, Xie Z, English AW, et al. Effect of exosomes from adipose-derived stem cells on the apoptosis of Schwann cells in peripheral nerve injury. CNS Neurosci Ther. 2020; 26: 189-96.

[27] Jiang L, Jones S, Jia X. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities. Int J Mol Sci. 2017; 18: 94.

[28] Yin L, Liu X, Shi Y, Ocansey DKW, Hu Y, Li X, et al. Therapeutic advances of stem cell-derived extracellular vesicles in regenerative medicine. Cell. 2020; 9: 707.

[29] Rao F, Zhang D, Fang T, Lu C, Wang B, Ding X, et al. Exosomes from human gingiva-derived mesenchymal stem cells combined with biodegradable chitin conduits promote rat sciatic nerve regeneration. Stem Cells Int. 2019; 2019: 2546367.

[30] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY). 2020; 367: eaau6977.

[31] van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19: 213-28.

[32] Zhou Y, Liu S, Zhao M, Wang C, Li L, Yuan Y, et al. Injectable extracellular vesicle-released self-assembling peptide nanofiber hydrogel as an enhanced cell-free therapy for tissue regeneration. J Control Release. 2019; 316: 93-104.

[33] Lv K, Li Q, Zhang L, Wang Y, Zhong Z, Zhao J, et al. Incorporation of small extracellular vesicles in sodium alginate hydrogel as a novel therapeutic strategy for myocardial infarction. Theranostics. 2019; 9: 7403-16.

[34] Pakulska MM, Ballios BG, Shoichet MS. Injectable hydrogels for central nervous system therapy. Biomed Mater. 2012; 7: 024101.

[35] Francis NL, Bennett NK, Halikere A, Pang ZP, Moghe PV. Self-assembling peptide nanofiber scaffolds for 3-D reprogramming and transplantation of human pluripotent stem cell-derived neurons. ACS biomaterials science & engineering. 2016; 2: 1030-8.

[36] Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol. 2005; 15: 378-86.

[37] Benton G, Arnaoutova I, George J, Kleinman HK, Koblinski J. Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev. 2014; 79-80: 3-18.

[38] Martin J, Martinez J, Mehdi A, Subra G. Silicone grafted bioactive peptides and their applications. Curr Opin Chem Biol. 2019; 52: 125-35.

[39] Singh S, Srivastava AK, Baranwal AK, Bhatnagar A, Das KK, Jaiswal S, et al. Efficacy of silicone conduit in the rat sciatic nerve repair model: journey of a thousand miles. Neurol India. 2021; 69: 318-25.

[40] Braga Silva J, Marchese GM, Cauduro CG, Debiasi M. Nerve conduits for treating peripheral nerve injuries: a systematic literature review. Hand Surg Rehabil. 2017; 36: 71-85.

[41] Chen W, Chang S, Yang C, Zhou J, Zhang H, Nie K, et al. Schwann cell-like cells derived from human amniotic mesenchymal stem cells promote sciatic nerve repair through an exosome-induced SOX2/FN1 pathway in vitro. Int J Mol Med. 2022; 49: 80.

[42] Xian P, Hei Y, Wang R, Wang T, Yang J, Li J, et al. Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019; 9: 5956-75.

[43] Lopez-Verrilli MA, Picou F, Court FA. Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia. 2013; 61: 1795-806.

[44] Huang B, Chen Z, Geng L, Wang J, Liang H, Cao Y, et al. Mucosal profiling of Pediatric-onset colitis and IBD reveals common Pathogenics and therapeutic pathways. Cell. 2019; 179: 1160-1176.e24.

[45] Bain JR, Mackinnon SE, Hunter DA.Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg. 1989; 83: 129-36.

[46] Wu P, Tong Z, Luo L, Zhao Y, Chen F, Li Y, et al. Comprehensive strategy of conduit guidance combined with VEGF producing Schwann cells accelerates peripheral nerve repair. Bioact Mater. 2021; 6: 3515-27.

[47] Svaren J, Meijer D. The molecular machinery of myelin gene transcription in Schwann cells. Glia. 2008; 56: 1541-51.

[48] Xie S, Lu F, Han J, Tao K, Wang H, Simental A, et al. Efficient generation of functional Schwann cells from adipose-derived stem cells in defined conditions. Cell cycle (Georgetown, Tex). 2017; 16: 841-51.

[49] Chen J, Ren S, Duscher D, Kang Y, Liu Y, Wang C, et al. Exosomes from human adipose-derived stem cells promote sciatic nerve regeneration via optimizing Schwann cell function. J Cell Physiol. 2019; 234: 23097-110.

[50] Yu M, Gu G, Cong M, Du M, Wang W, Shen M, et al. Repair of peripheral nerve defects by nerve grafts incorporated with extracellular vesicles from skin-derived precursor Schwann cells. Acta Biomater. 2021; 134: 190-203.

[51] Lopez-Leal R, Court FA. Schwann cell exosomes mediate neuron-glia communication and enhance axonal regeneration. Cell Mol Neurobiol. 2016; 36: 429-36.

[52] Wei Z, Fan B, Ding H, Liu Y, Tang H, Pan D, et al. Proteomics analysis of Schwann cell-derived exosomes: a novel therapeutic strategy for central nervous system injury. Mol Cell Biochem. 2019; 457: 51-9.

[53] Cerqueira SR, Lee YS, Cornelison RC, Mertz MW, Wachs RA, Schmidt CE, et al. Decellularized peripheral nerve supports Schwann cell transplants and axon growth following spinal cord injury. Biomaterials. 2018; 177: 176-85.

[54] Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, Pearse DD. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci. 2005; 25: 1169-78.

[55] Meijs MF, Timmers L, Pearse DD, Tresco PA, Bates ML, Joosten EA, et al. Basic fibroblast growth factor promotes neuronal survival but not behavioral recovery in the transected and Schwann cell implanted rat thoracic spinal cord. J Neurotrauma. 2004; 21: 1415-30.

[56] Jessen KR, Mirsky R. The repair Schwann cell and its function in regenerating nerves. J Physiol. 2016; 594: 3521-31.

[57] Carr MJ, Johnston AP. Schwann cells as drivers of tissue repair and regeneration. Curr Opin Neurobiol. 2017; 47: 52-7.

[58] Zhou Y, Notterpek L. Promoting peripheral myelin repair. Exp Neurol. 2016; 283: 573-80.

[59] Hoyng SA, De Winter F, Gnavi S, de Boer R, Boon LI, Korvers LM, et al. A comparative morphological, electrophysiological and functional analysis of axon regeneration through peripheral nerve autografts genetically modified to overexpress BDNF, CNTF, GDNF, NGF, NT3 or VEGF. Exp Neurol. 2014; 261: 578-93.

[60] Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A. 2002; 99: 11946-50.

[61] Mokarram N, Merchant A, Mukhatyar V, Patel G, Bellamkonda RV. Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials. 2012; 33: 8793-801.

[62] Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organ. 2010; 6: 107-14.